<DOC>
<DOCNO>
EP-0004793
</DOCNO>
<TEXT>
<DATE>
19791017
</DATE>
<IPC-CLASSIFICATIONS>
C07D-405/06 A61K-31/513 A61K-31/506 C07D-233/64 C07D-239/00 A61P-1/14 C07D-405/02 C07D-403/00 A61P-1/00 C07D-405/00 C07D-403/02 C07D-405/12 C07D-403/14 C07D-401/14 C07D-239/47 C07D-401/06 C07D-239/46 <main>C07D-239/46</main> C07D-401/00 C07D-405/14 C07D-401/02 C07D-233/00 C07D-403/12 A61K-31/505 A61P-29/00 
</IPC-CLASSIFICATIONS>
<TITLE>
2-nitro aminopyrimidone derivatives, a process for their preparation and their use to prepare 2-aminopyrimidone derivatives which have histamine h2-antagonist activity.
</TITLE>
<APPLICANT>
smith kline french labgb<sep>smith kline & french laboratories limited<sep>smith kline &amp; french laboratories limitedmundellswelwyn garden city hertfordshire, al7 1eygb<sep>smith kline & french laboratories limited<sep>
</APPLICANT>
<INVENTOR>
brown thomas henry<sep>brown, thomas henry<sep>brown, thomas henry115 daniellswelwyn garden city hertfordshiregb<sep>brown, thomas henry<sep>brown, thomas henry115 daniellswelwyn garden city hertfordshiregb<sep>
</INVENTOR>
<ABSTRACT>
2-aminopyrimidones which are histamine h₂-antagonists  having the structure    in which het is a nitrogen-containing 5- or 6-membered fully  unsaturated heterocyclic group, m is 0 or 1, y is methylene,  oxygen or sulphur, n is 2 or 3, z is hydrogen or lower alkyl, a  is an alkylene group or an alkylene group interrupted by  oxygen or sulphur, and b is hydrogen or a methyl, cycloalkyl,  heteroaryl, phenyl, naphthyl, benzodioxolyl or dihydrobenzodioxinyl  group, are prepared by a process in which an  amine het-(ch₂)my(ch₂)nnh₂ is reacted with a 2-nitroaminopyrimidone  of structure    the new 2-nitroaminopyrimidone intermediates are prepared  by reacting nitroguanidine with an oxoester ro₂c-ch(coz)-a-b  where r is lower alkyl.  
</ABSTRACT>
</TEXT>
</DOC>
